Osteologie 2009; 18(04): 276-284
DOI: 10.1055/s-0037-1619904
Seltene Knochenerkrankungen
Schattauer GmbH

Die Gorham-Stout-Erkrankung

Gorham-Stout-Disease
L. Seefried
1   Muskuloskelettales Centrum Würzburg, Universität Würzburg, Orthopädische Klinik König-Ludwig-Haus
,
R. Ebert
1   Muskuloskelettales Centrum Würzburg, Universität Würzburg, Orthopädische Klinik König-Ludwig-Haus
,
S. Bau
1   Muskuloskelettales Centrum Würzburg, Universität Würzburg, Orthopädische Klinik König-Ludwig-Haus
,
W. Kenn
2   Institut für Röntgendiagnostik, Universitätsklinikum Würzburg
,
J. Zustin
3   Institut für Pathologie, Universitätsklinikum Hamburg-Eppendorf
,
M. Rudert
1   Muskuloskelettales Centrum Würzburg, Universität Würzburg, Orthopädische Klinik König-Ludwig-Haus
,
F. Jakob
1   Muskuloskelettales Centrum Würzburg, Universität Würzburg, Orthopädische Klinik König-Ludwig-Haus
› Author Affiliations
Further Information

Publication History

eingereicht: 14 October 2009

angenommen: 15 October 2009

Publication Date:
30 December 2017 (online)

Zusammenfassung

Die Gorham-Stout-Erkrankung (Gorham-Stout-Disease / GSD) ist charakterisiert durch eine spontane, massive, in der Regel monozentrische Osteolyse, häufig koinzident mit einer lokalen Proliferation kleiner Blut- und/oder Lymphgefäße. Als eigenständige Entität wurde das Krankheitsbild erstmals 1954 beschrieben. Die Erkrankung ist mit etwa 200 in der Literatur beschriebenen Fällen sehr selten und ihre Pathogenese ist bis heute weitestgehend unklar. Diskutiert wird eine Hämangio-/Lymphangiomatose mit konsekutiver Zerstörung des Knochens sowie eine osteoklastäre Überstimulation mit reaktiver, meist von vaskulären Strukturen durchsetzter fibröser Proliferation. Ausgangspunkt können grundsätzlich alle Skelettbereiche sein mit progredientem, auch gelenkübergreifendem Befall benachbarter Knochenund Weichteilstrukturen. Prädilektionsstellen sind der Schultergürtel, das Becken sowie der Kieferbereich. Die Symptome treten oft erst spät auf und sind eher unspezifisch mit uncharakteristischen Schmerzen, Schwellungen oder pathologischen Frakturen. Die Diagnose wird anhand der klinischen, laborchemischen, radiologischen und histopathologischen Befunde nach Ausschluss anderer Ursachen einer lokalen Osteolyse gestellt. Ein etabliertes Therapieverfahren existiert nicht. Wiederholt angewandte Maßnahmen sind die Strahlentherapie und die Gabe von Interferon α-2b zur Unterbindung der vaskulären Proliferationen, Bisphosphonate und Vitamin D zur Stabilisierung des Knochens sowie chirurgische Verfahren zur Entfernung der Läsionen und funktionellen Rekonstruktion. Die prognostische Bandbreite reicht von spontanem Sistieren der Erkrankung bis hin zu komplikativen Verläufen mit hoher Letalität.

Summary

Gorham-Stout Disease is characterised by spontaneous, massive, usually monocentric os- teolysis, frequently involving local proliferation of small blood or lymph vessels. It was first specified as a discrete medical entity in 1954. With about 200 cases reported in the literature, the illness is very rare and its pathogenesis is still widely elusive. Common hypotheses propose hemangiomatosis/lymphangiomatosis with consecutive deterioration of bone as well as overstimulation of osteoclasts with reactive proliferation of fibrous, usually vascularised tissue. Generally, the disease may start at any site of the skeleton with progressive affection of adjacent bones and soft tissue. Common sites include shoulder girdle, pelvis and the jaw. Symptoms often occur tardily and are rather unspecific with pain, swelling or pathologic fractures. Diagnosis is based on laboratory, radiological and histopathological findings and confirmed by exclusion of other causes of local osteolysis. There is no standardized, established therapeutic procedure. Commonly applied measures comprise radiation therapy and administration of interferon α-2b to suppress vascular proliferation, bisphosphonates and vitamin D to stabilize boney structures as well as surgical procedures for removal of affected tissue and – if necessary – functional reconstruction. Prognosis ranges from spontaneous cessation of the disease process to complicated courses with a high rate of lethality.

 
  • Literatur

  • 1 Gorham LW, Stout AP. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 1955; 37-A (05) 985-1004.
  • 2 Heffez L, Doku HC, Carter BL, Feeney JE. Perspec- tives on massive osteolysis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 1983; 55 (04) 331-343.
  • 3 Hardegger F, Simpson LA, Segmueller G. The syn- drome of idiopathic osteolysis. Classification, review, and case report. J Bone Joint Surg Br 1985; 67 (01) 88-93.
  • 4 Gorham LW, Stout AP. Hemangiomatosis and its relation to massive osteolysis. Trans Assoc Am Physicians 1954; 67: 302-307.
  • 5 Jackson JBS. A boneless arm. Boston Med Surg J 1839; 18: 368-369.
  • 6 Boston_Society_for_Medical_Improvement. Dwight T, Porter CB. Absorption of the Humerus after Fracture. Boston Med Surg J 1872; X (15) 245-247.
  • 7 Gorham LW, Wright AW, Shultz HH, Maxon Jr FC. Disappearing bones: a rare form of massive osteolysis; report of two cases, one with autopsy findings. Am J Med 1954; 07 (05) 674-682.
  • 8 Chung C, Yu JS, Resnick D. et al. Gorham syndrome of the thorax and cervical spine: CT and MRI findings. Skeletal Radiol 1997; 26 (01) 55-59.
  • 9 Choma ND, Biscotti CV, Bauer TW. et al. Gorham’s syndrome: a case report and review of the literature. Am J Med 1987; 83 (06) 1151-1156.
  • 10 Moller G, Priemel M, Amling M. et al. The Gorham- Stout syndrome (Gorham’s massive osteolysis). A report of six cases with histopathological findings. J Bone Joint Surg Br 1999; 81 (03) 501-506.
  • 11 Pedicelli G, Mattia P, Zorzoli AA. et al. Gorham syndrome. Jama 1984; 252 (11) 1449-1451.
  • 12 Florchinger A, Bottger E, Claass-Bottger F. et al. Gorham-Stout syndrome of the spine. Case report and review of the literature. Rofo 1998; 168 (01) 68-76.
  • 13 Rudert M, Gross W, Kirschner P. Gorham-Stout massive ostelysis. A case report. Unfallchirurg 1995; 98 (02) 102-104.
  • 14 Knoch HG. Die Gorhamsche Krankheit aus klinischer Sicht. Zentralbl Chir 1963; 18: 674-683.
  • 15 Kawasaki K, Ito T, Tsuchiya T, Takahashi H. Is angiomatosis an intrinsic pathohistological feature of massive osteolysis? Report of an autopsy case and a review of the literature. Virchows Arch 2003; 442 (04) 400-406.
  • 16 Heyden G, Kindblom LG, Nielsen JM. Disappearing bone disease. A clinical and histological study. J Bone Joint Surg Am 1977; 59 (01) 57-61.
  • 17 Franchi A, Bertoni F, Bacchini P. et al. CD105/endoglin expression in Gorham disease of bone. J Clin Pathol 2009; 62 (02) 163-167.
  • 18 Warrington K, Hillarby MC, Li C. et al. Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells. Anticancer Res 2005; 25 (3B): 1851-1864.
  • 19 Radhakrishnan K, Rockson SG. Gorham’s disease: an osseous disease of lymphangiogenesis?. Ann N Y Acad Sci 2008; 1131: 203-205.
  • 20 Hagendoorn J, Padera TP, Yock TI. et al. Platelet-derived growth factor receptor-beta in Gorham’s disease. Nat Clin Pract Oncol 2006; 03 (12) 693-697.
  • 21 Bruch-Gerharz D, Gerharz CD, Stege H. et al. Cutaneous lymphatic malformations in disappearing bone (Gorham-Stout) disease: a novel clue to the pathogenesis of a rare syndrome. J Am Acad Dermatol 2007; 56 (Suppl. 02) S21-S25.
  • 22 Devlin RD, Bone 3rd HG, Roodman GD. Interleu- kin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin En- docrinol Metab 1996; 81 (05) 1893-1897.
  • 23 Hirayama T, Sabokbar A, Itonaga I. et al. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol 2001; 195 (05) 624-630.
  • 24 Colucci S, Taraboletti G, Primo L. et al. Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res 2006; 21 (02) 207-218.
  • 25 Diaz-Ramon C, Fernandez-Latorre F, Revert-Ventura A. et al. Idiopathic progressive osteolysis of craniofacial bones. Skeletal Radiol 1996; 25 (03) 294-297.
  • 26 Feigl D, Marmor A. Gorham’s disease of the clavicle with bilateral pleural effusions. Eight years later. Chest 1987; 92 (01) 189.
  • 27 Atalabi OM, Fishman SJ, Kozakewich HP. et al. A lethal form of Gorham disease associated with extensive musculoskeletal pneumatosis: case report and review of the literature. Skeletal Radiol 2008; 37 (11) 1041-1046.
  • 28 Boyle MJ, Alison P, Taylor G, Lightbourne BA. A case of Gorham’s disease complicated by bilateral chylothorax. Heart Lung Circ 2008; 17 (01) 64-66.
  • 29 Cannon SR. Massive osteolysis. A review of seven cases. J Bone Joint Surg Br 1986; 68 (01) 24-28.
  • 30 Zhong LP, Zheng JW, Zhang WL. et al. Multicentric Gorham’s disease in the oral and maxillofacial region: report of a case and review of the literature. J Oral Maxillofac Surg 2008; 66 (05) 1073-1076.
  • 31 Rubel IF, Carrer A, Gilles JJ. et al. Progressive Gorham disease of the forearm. Orthopedics 2008; 31 (03) 284.
  • 32 Patel DV. Gorham’s disease or massive osteolysis. Clin Med Res 2005; 03 (02) 65-74.
  • 33 Feigl D, Seidel L, Marmor A. Gorham’s disease of the clavicle with bilateral pleural effusions. Chest 1981; 79 (02) 242-244.
  • 34 Hammer F, Kenn W, Wesselmann U. et al. Gorham- Stout disease - stabilization during bisphosphonate treatment. J Bone Miner Res 2005; 20 (02) 350-353.
  • 35 Dominguez R, Washowich TL. Gorham’s disease or vanishing bone disease: plain film, CT, and MRI findings of two cases. Pediatr Radiol 1994; 24 (05) 316-318.
  • 36 Dominguez BFuentes, Garcia-Gil D, Jimeno A, Garcia-Lechuz JM. Gorham-Stout syndrome in a patient with HIV infection. Med Clin (Barc) 2008; 131 (01) 36-37.
  • 37 Hejgaard N, Olsen PR. Massive Gorham osteolysis of the right hemipelvis complicated by chylothorax: report of a case in a 9-year-old boy successfully treated by pleurodesis. J Pediatr Orthop 1987; 07 (01) 96-99.
  • 38 Meltzer E, Goshen E, Fridman E, Sidi Y. Diffuse lymphangiomatosis - a fatal case with atypical skeletal features. Am J Med Sci 2008; 336 (05) 445-448.
  • 39 Spieth ME, Greenspan A, Forrester DM. et al. Gor- ham’s disease of the radius: radiographic, scintigraphic, and MRI findings with pathologic correlation. A case report and review of the literature. Skeletal Radiol 1997; 26 (11) 659-663.
  • 40 Livesley PJ, Saifuddin A, Webb PJ. et al. Gorham’s disease of the spine. Skeletal Radiol 1996; 25 (04) 403-405.
  • 41 Sage MR, Allen PW. Massive osteolysis. Report of a case. J Bone Joint Surg Br 1974; 56 (01) 130-135.
  • 42 Kenn W, Eck M, Allolio B. et al. Erdheim-Chester disease: evidence for a disease entity different from Langerhans cell histiocytosis? Three cases with de- tailed radiological and immunohistochemical analysis. Hum Pathol 2000; 31 (06) 734-739.
  • 43 Malik R, Malik R, Tandon S, Tandon P. Skeletal angiomatosis - rare cause of bone destruction: a case report with review of literature. Indian J Pathol Microbiol 2008; 51 (04) 515-518.
  • 44 Miller GG. Treatment of chylothorax in Gorham’s disease: case report and literature review. Can J Surg 2002; 45 (05) 381-382.
  • 45 Patrick JH. Massive osteolysis complicated by chylothorax successfully treated by pleurodesis. J Bone Joint Surg Br 1976; 58 (03) 347-349.
  • 46 Aoki M, Kato F, Saito H. et al. Successful treatment of chylothorax by bleomycin for Gorham’s disease. Clin Orthop Relat Res 1996; 330: 193-197.
  • 47 Tie ML, Poland GA, Rosenow 3rd EC. Pleural effusion: a complication of Gorham’s disease. Pediatr Radiol 1994; 24 (07) 542.
  • 48 Pfleger A, Schwinger W, Maier A. et al. Gorham- Stout syndrome in a male adolescent-case report and review of the literature. J Pediatr Hematol Oncol 2006; 28 (04) 231-233.
  • 49 Hagberg H, Lamberg K, Astrom G. Alpha-2b inter- feron and oral clodronate for Gorham’s disease. Lancet 1997; 350 9094 1822-1823.
  • 50 Bek V, Haicl Z, Kolar J, Bednar B. Radiotherapy in massive angiomatous osteolysis (Gorham-Stout’s syndrome). Strahlentherapie 1981; 157 (12) 813-818.
  • 51 Ogita S, Deguchi E, Tokiwa K. et al. Ongoing osteolysis in patients with lymphangioma. J Pediatr Surg 1998; 33 (01) 45-48.
  • 52 Takahashi A, Ogawa C, Kanazawa T. et al. Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: a severe case of Gorham-Stout syndrome. J Pediatr Surg 2005; 40 (03) E47-E50.
  • 53 Kose M, Pekcan S, Dogru D. et al. Gorham-Stout Syndrome with chylothorax: successful remission by interferon alpha-2b. Pediatr Pulmonol 2009; 44 (06) 613-615.
  • 54 Tsang WM, Tong AC, Chow LT, Ng IO. Massive osteolysis (Gorham disease) of the maxillofacial skeleton: report of 2 cases. J Oral Maxillofac Surg 2004; 62 (02) 225-230.
  • 55 Ferretti G, Fabi A, Carlini P. et al. Zoledronic-acid- induced circulating level modifications of angiogenic factors, metalloproteinases and proinflam- matory cytokines in metastatic breast cancer patients. Oncology 2005; 69 (01) 35-43.
  • 56 Phillips RM, Bush Jr. OB, Hall HD. Massive osteolysis (phantom bone, disappearing bone). Report of a case with mandibular involvement. Oral Surg Oral Med Oral Pathol 1972; 34 (06) 886-896.
  • 57 Ross JL, Schinella R, Shenkman L. Massive osteolysis. An unusual cause of bone destruction. Am J Med 1978; 65 (02) 367-372.
  • 58 Poldervaart MT, Breugem CC, Speleman L, Pasmans S. Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature. J Craniofac Surg 2009; 20 (04) 1159-1162.